Solitron Devices, Inc. (OTCPK:SODI) Is Tim Eriksen building a baby Berkshire?

Provided to subscribers June 22nd.

Here’s the latest from Canadian Value Investors!

  • Graftech Note Issuance – Oof

  • Need to park cash? Use SHV

  • Solitron Devices, Inc. (OTCPK:SODI) Is Tim Eriksen building a baby Berkshire?

  • Bonus Bloomberg – Defense spending is booming

Graftech NYSE:EAF New Note Issuance

Disclosure: We do not own this.

We posted about Graftech on May 28th (see member post). Oof. First, operational hiccups at Graftech $EAF last year are still hanging around causing sales problems almost a year later, and now another $25MM a year of CF disappearing to higher interest costs vs a year ago. This effectively covers the term facility so at least covenants probably aren’t a concern now. Still on the sidelines. https://www.graftech.com/investors/news/news-details/2023/GrafTech-Prices-Offering-of-450-Million-of-Senior-Secured-Notes/default.aspx

Need to park cash? Use SHV

We usually do not carry much cash, but sometimes we are between ideas and trades. One place to park your cash is ishares short-term treasury ETF, SHV. Why SHV? It only holds U.S. Treasury bonds that mature in less than 1 year, so you have very little duration risk. Current yield to maturity is 5.11%.

This is the best we have found for a as close to riskless ETF to park cash. We have not been able to find a Canadian dollar equivalent; all of the ETFs we have looked at have long duration and/or corporate issuances. We have no interest in taking on either of these risks with our cash. If you have a better U.S. dollar ETF or an idea for a Canadian dollar denominated one, please let us know!

https://www.ishares.com/us/products/239466/ishares-short-treasury-bond-etf

Solitron Devices, Inc. (OTCPK:SODI) Is Tim Eriksen building a baby Berkshire?

Disclosure: We currently own this.

For readers that have been around for awhile, you know that we have been following Solitron Devices, Inc. for a few years now. Our first article was May 2022 - Reading the Turnaround Tea Leaves - followed by an update in July. Our writings have typically focused on things that we have acquired but have had several requests for articles covering what we have not purchased and why. This is a great example. We think there might be something here, but have not yet pulled the trigger. Here’s why.

Since our last update, CEO Tim Eriksen and company have been busy.

As a quick refresh:

-Solitron makes power control modules/junctions/etc, for weapons systems and airplanes like the B-52 bomber. This is typically sticky business supporting the life of the system, so long as you perform. And lives can be long, shown best by the B-52 that has been around in one form or another since 1952.

-Tim Eriksen, activist investor turned CEO, is a few years into a turnaround with major step changes, including moving their facility to a cheaper/better owned facility and is in the middle of rationalizing and improving production.

-The U.S. government continues to prioritize smaller contractors as part of their Increasing Opportunities for Small Businesses policy (see original article).

-We stayed on the sidelines last year primarily because 1) we were unsure of the success of their plant move (i.e. what true run-rate sales and costs would become), and 2) we were unsure where they would put their cash. We now have an answer to one and almost both questions.

-Since our initial check, the Ukraine war has create a bit of an embarrassing weapons stockpile problem for the U.S. “Slower manufacturing and expenditure of reserves in Ukraine have many worried about the state of U.S. munition stockpiles and military readiness.” https://www.heritage.org/defense/report/rapidly-depleting-munitions-stockpiles-point-necessary-changes-policy

Our initial analysis and July update was as follows. How have things gone? They just provided their (off-cycle February) 2023 year-end financials.

Key highlights:

1) The trickle down of the U.S. stockpile problem leading to sales – “As we noted in our fiscal third quarter release, in December 2022 the President signed the $1.7 trillion omnibus spending bill.  Included in the bill are appropriations to replenish supplies used in Ukraine and to increase stockpiles.  A number of programs are included in the spending, including two that represent Solitron‘s two largest revenue sources.  The increased stockpiles program is a multi-year program that we currently expect to add approximately $20 million in total revenues starting in late calendar 2024 and running through 2028, or approximately $4 million annually.  Actual contract awards are expected to occur by the fall of 2024.”

2) Sales were impacted by the plant move as expected. “Bookings were strong in the quarter, exceeding $3.5 million and backlog finished at $9.1 million, our highest quarter end level since February 2021.” We note that some 2022 sales were actually pulled from 2023 in advance of the move.

3) Most importantly, it looks like Tim and Co are indeed trying to use the company as platform to grow into something larger through public holdings and acquisitions (see notes below). They had $4.3MM of cash and investments at year-end. For us, this means we need to ignore the surplus cash and instead make assumptions about expected returns.

“We had significant unrealized gains on investments during the fiscal fourth quarter and fiscal year 2023. In the middle of the fiscal year the Board approved a revision to our approach toward investments to allow for more concentrated positions. We purchased 1.1% and 1.5%, respectively, of the outstanding shares of two small community banks that were recipients of the Emergency Capital Investment Program (ECIP). …

On June 1 Solitron signed a non-binding term sheet for a potential acquisition of a target company which produces electronic components primarily for the medical industry.  We are now in a due diligence process which is estimated to last approximately 75 days.   The terms set forth in the term sheet contemplate that, if completed, the acquisition would be funded from cash and securities on hand.  An initial payment of approximately $3.0 million would be due upon close.  Additional earnout payments of up to approximately $450,000 each would be payable over each of the next three years.   The target company produces electronic components primarily for the medical industry.  Revenue for 2022 was approximately $5.9 million as compared to $5.5 million in 2021.  One customer accounted for approximately 90% of revenues.   We can make no guarantees that the transaction will be able to be consummated, or if it is that it will yield the results or benefits desired or anticipated.”

They are also doing concentrated bets on holdings; these appear to crossover with Tim Eriksen’s fund. https://www.eriksencapitalmgmt.com/manager

We had significant unrealized gains on investments during the fiscal fourth quarter and fiscal year 2023.  In the middle of the fiscal year the Board approved a revision to our approach toward investments to allow for more concentrated positions.  We purchased 1.1% and 1.5%, respectively, of the outstanding shares of two small community banks that were recipients of the Emergency Capital Investment Program (ECIP).   Due to increased interest rates, we also moved most of our cash to treasury bills which is considered Short-term investments on the balance sheet.    

Our takeaways

-

Bloomberg - Defense Spending is Booming

Bloomberg - Has the Ukraine war started a new arms race? Yes, to judge by figures published on Monday by the Stockholm International Peace Research Institute, a think-tank. Global defence spending rose by 3.7% in real terms in 2022 to a record $2.24trn. It shot up by 9.2% in Russia and septupled in Ukraine. Farther west in Europe, military spending grew by 3.6% to levels unseen since the end of the cold war.

Yet the picture is fuzzy. The economic burden of armed forces, at 2.2% of GDP, remains close to its post-cold-war low. In part, the world economy has grown. Of the biggest arms spenders, America was flat and China dipped as a share of GDP. But many of the promised spending increases are yet to come. Inflation may abate. And geopolitical tension—a long war in Ukraine, and talk of a future one between America and China—will push countries to buy ever more weapons.